Measuring cognitive processes in patients with parkinson's disease

1991 ◽  
Vol 6 (4) ◽  
pp. 319-325 ◽  
Author(s):  
M. Fioravanti ◽  
R. W. Kulhavy ◽  
F. D. Cesare ◽  
L. C. Caterino ◽  
W. A. Stock
2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Matthew J. D. Pilgrim ◽  
Zhen-Yi Andy Ou ◽  
Madeleine Sharp

AbstractAn important aspect of managing a limited cognitive resource like attention is to use the reward value of stimuli to prioritize the allocation of attention to higher-value over lower-value stimuli. Recent evidence suggests this depends on dopaminergic signaling of reward. In Parkinson’s disease, both reward sensitivity and attention are impaired, but whether these deficits are directly related to one another is unknown. We tested whether Parkinson’s patients use reward information when automatically allocating their attention and whether this is modulated by dopamine replacement. We compared patients, tested both ON and OFF dopamine replacement medication, to older controls using a standard attention capture task. First, participants learned the different reward values of stimuli. Then, these reward-associated stimuli were used as distractors in a visual search task. We found that patients were generally distracted by the presence of the distractors but that the degree of distraction caused by the high-value and low-value distractors was similar. Furthermore, we found no evidence to support the possibility that dopamine replacement modulates the effect of reward on automatic attention allocation. Our results suggest a possible inability in Parkinson’s patients to use the reward value of stimuli when automatically allocating their attention, and raise the possibility that reward-driven allocation of resources may affect the adaptive modulation of other cognitive processes.


2020 ◽  
Author(s):  
Marit Ruitenberg ◽  
Nelleke van Wouwe ◽  
Scotty Wylie ◽  
Elger Abrahamse

Parkinson’s disease (PD) is a neurological disorder associated primarily with overt motor symptoms. Several studies show that PD is additionally accompanied by impairments in covert cognitive processes controlling motor functioning (e.g., action planning, adaptation, inhibition), and that dopaminergic medication may modulate such action control. In this review we aim to leverage findings from studies in this domain to elucidate the role of dopamine (DA) in action control. A qualitative review of studies that investigated the effects of medication status (on vs. off) on action control in PD suggests a component-specific role for DA in action control, although the expression of medication effects depends on characteristics of both the patients and experimental tasks used to measure action control. We discuss these results in the light of findings from other research lines examining the role of DA in action control (e.g., animal research, pharmacology), and recommend that future studies use multi-method, within-subject approaches to model DA effects on action control across different components as well as underlying striatal pathways (ventral vs. dorsal).


2000 ◽  
Vol 7 (5) ◽  
pp. 473-483 ◽  
Author(s):  
S. Blanchet ◽  
R. M. Marie ◽  
F. Dauvillier ◽  
B. Landeau ◽  
K. Benali ◽  
...  

2020 ◽  
Vol 153 ◽  
pp. 65-79 ◽  
Author(s):  
Bahar Güntekin ◽  
Tuba Aktürk ◽  
Ebru Yıldırım ◽  
Nesrin Helvacı Yılmaz ◽  
Lütfü Hanoğlu ◽  
...  

2019 ◽  
Vol 1 ◽  
pp. 13-20
Author(s):  
Attakias T. Mertens ◽  
Jonathan B. Santo ◽  
Katerina Markopoulou ◽  
Bruce A. Chase

2003 ◽  
Vol 9 (7) ◽  
pp. 1078-1087 ◽  
Author(s):  
GREGORY P. CRUCIAN ◽  
ANNA M. BARRETT ◽  
DAVID W. BURKS ◽  
ALONSO R. RIESTRA ◽  
HEIDI L. ROTH ◽  
...  

Deficits in visual-spatial ability can be associated with Parkinson's disease (PD), and there are several possible reasons for these deficits. Dysfunction in frontal–striatal and/or frontal–parietal systems, associated with dopamine deficiency, might disrupt cognitive processes either supporting (e.g., working memory) or subserving visual-spatial computations. The goal of this study was to assess visual–spatial orientation ability in individuals with PD using the Mental Rotations Test (MRT), along with other measures of cognitive function. Non-demented men with PD were significantly less accurate on this test than matched control men. In contrast, women with PD performed similarly to matched control women, but both groups of women did not perform much better than chance. Further, mental rotation accuracy in men correlated with their executive skills involving mental processing and psychomotor speed. In women with PD, however, mental rotation accuracy correlated negatively with verbal memory, indicating that higher mental rotation performance was associated with lower ability in verbal memory. These results indicate that PD is associated with visual–spatial orientation deficits in men. Women with PD and control women both performed poorly on the MRT, possibly reflecting a floor effect. Although men and women with PD appear to engage different cognitive processes in this task, the reason for the sex difference remains to be elucidated. (JINS, 2003, 9, 1078–1087.)


Sign in / Sign up

Export Citation Format

Share Document